StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) stock

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was $14.58B, up 22.9% from the year before. Over ten years it grew 15.9% a year on average. The highest annual figure on record is $14.58B in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$14.58B+22.9%
FY2024Dec 31, 2024$11.86B+14.7%
FY2023Dec 31, 2023$10.35B+5.5%
FY2022Dec 31, 2022$9.81B+64.5%
FY2021Dec 31, 2021$5.96B+24.3%
FY2020Dec 31, 2020$4.80B+61.6%
FY2019Dec 31, 2019$2.97B+13.4%
FY2018Dec 31, 2018$2.62B-26.8%
FY2017Dec 31, 2017$3.58B-13.7%
FY2016Dec 31, 2016$4.15B+24.7%
FY2015Dec 31, 2015$3.32B–

More AstraZeneca figures

See a number that looks wrong?